Sept. 27, 2010 -- Women with breast cancer have an increased risk for depression, and now new research finds the same thing to be true for the men in their lives.
The study followed more than a million men enrolled in a nationwide Danish health registry for 13 years.
Those with partners diagnosed with breast cancer during this period were almost 40% more likely to be hospitalized for depression, bipolar disease, or another mood disorder compared to men whose partners did not have breast cancer.
The hospitalization rate was almost fourfold higher for men whose partners died of the disease when compared to men whose partners survived breast cancer.
Study researcher Christoffer Johansen, MD, PhD, of Denmark’s Institute of Cancer Epidemiology says the partners of women with breast cancer may be more at risk because their emotional needs are often overlooked.
The study appears today online in the journal Cancer, published by the American Cancer Society.
“We found that spouses may be as vulnerable, or even more vulnerable, to serious depression as the wives who have breast cancer,” Johansen tells WebMD.
Several smaller studies have shown an increase in depression risk among partners of cancer patients, while others have not.
But the newly published study is the first to use data from a nationwide registry of depression and other mood-disorder-related hospitalizations to objectively assess the risk of severe depression and mood disorders among partners of breast cancer patients, also identified through a national health registry.
Between 1994 and 2006, roughly 20,500 women with partners received a diagnosis of breast cancer. During the same period, 180 of the partners were hospitalized for depression or other serious mood disorders.
This compared to just over 12,000 hospitalizations among 1.1 million men with wives or girlfriends who were not diagnosed with breast cancer.
Among men with a partner diagnosed with breast cancer, the risk of hospitalization for depression increased by 50% among the partners of women whose breast cancer advanced after initial treatment, and the risk was 3.6-times higher for men whose partners died of the disease.